[TOVX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
31-Mar-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 62.32%
YoY- 45.11%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 0 0 0 0 -972 293 356 -
PBT -11,893 -1,826 -1,716 -1,849 -2,662 -1,098 -1,680 266.50%
Tax 180 94 149 -654 541 160 760 -61.55%
NP -12,066 -1,930 -1,872 -1,200 -3,185 -1,098 -1,680 270.03%
Tax Rate - - - - - - - -
Total Cost 12,066 1,930 1,872 1,200 2,213 1,391 2,035 225.82%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 0.00 0.00 0.00 0.00 327.60 -374.20 -472.46 -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -102.55 -20.24 -19.85 -13.12 -37.64 -13.68 -21.09 185.64%
EPS Diluted -95.20 -20.24 -19.85 -13.12 -35.62 -13.68 -21.09 171.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.